Thus, at the onset of T1DM, once the child is clinically stable, National and International Guidelines for Diabetes Management recommend screening for anti-thyroid peroxidase and anti-transglutaminase antibodies, TSH, and free T4. This evidence concerns the gene TPO and diabetes mellitus.